Bilastine is a white to off-white crystalline powder that is sparingly soluble in methylene chloride and practically insoluble in acetone. It has an assay range of 98.0% to 102.0%.

Products still subject to third-party patent protection might be available solely for R&D purposes.

Dexmedetomidine Hydrochloride (HCl) stands as a pivotal chemical for the pharmaceutical sector, utilized primarily as a sedative, anxiolytic, and analgesic agent. Under the umbrella of performance materials, this product maintains a strong presence within medical settings, with a focus on providing sedation for non-intubated patients before and/or during surgical and other procedures. It's also used in intensive care sedation for intubated, mechanically ventilated patients. Manufactured in adherence to stringent standards, Dexmedetomidine HCl is a white or almost white powder that dissolves freely in DMSO and is slightly soluble in methanol and water, ensuring its ease of adoption in various pharmaceutical formulations. Our product complies with the United States Drug Master File (US DMF), and proudly carries the European Union Good Manufacturing Practice (EU GMP) certification, attesting to its high-grade quality and the thoroughness of its production process. Beyond its uses, this product is defined by its anatomical therapeutic chemical classification, which refers to a system used for the classification of drugs. A prime focus is on organic purity, with individual impurities like Dimethylphenylethyl imidazole and Levomedetomidine meticulously controlled to exceed pharmacopeial standards. Our product boasts a laudable enantiomeric purity and an assay value ranging between 98.0% and 102.0%, exemplifying its consistency and reliability. It is vital to note that our Dexmedetomidine HCl maintains permissible thresholds for residual solvents, ensuring the safety and efficacy of the drug. The list of related substances and required specifications for solvents like acetone, ethanol, and benzene are rigorously quantified below recognized safety limits, aligning with the highest regulatory expectations. We ensure that each batch is synonymous with excellence, a testament to our unwavering commitment to the highest quality standards in pharmaceutical ingredients. By choosing our Dexmedetomidine HCl, stakeholders in the pharmaceutical industry can confidently incorporate a product that is not only potent and versatile but also conforms to the critical parameters of drug safety and manufacturing excellence. For more information, please visit our website or contact our customer service team, who stand ready to assist with product inquiries and logistic details.

Products still subject to third-party patent protection might be available solely for R&D purposes.

Refarmed Chemicals presents Ciprofibrate, a crucial pharmaceutical material developed for clinical efficacy in managing lipid disorders. Developed with the utmost precision, Ciprofibrate is a fibrate-class drug specially formulated as a therapeutic agent to regulate high levels of cholesterol and triglycerides, factors leading to cardiovascular diseases. Our product is synthesized with rigorous compliance to quality standards, evidenced by its Good Manufacturing Practice (GMP) certification. The drug appears as a white or slightly yellow-white crystalline powder, indicative of its purity. Highly soluble in anhydrous ethanol and toluene yet practically insoluble in water, Ciprofibrate facilitates flexibility in pharmaceutical formulation, allowing for both tablet and capsule dosage forms in strengths of 100mg and 200mg. Targeting primary hypercholesterolemia (type IIa or IIb), mixed dyslipidemia, and as preventive treatment against cardiovascular events in high cholesterol patients, Ciprofibrate's composition facilitates the acceleration of cholesterol and triglyceride breakdown and removal from the body. Recommended for bi-daily intake alongside meals, the treatment's efficacy is augmented by adherence to healthy lifestyle choices, including a balanced diet and regular exercise. Safety parameters dictate careful administration especially to those with a history of gallbladder disease, and periodic liver function evaluations are advised. Contraindications include severe renal or hepatic conditions, pregnancy, breastfeeding, or known hypersensitivity to fibrates. Consultation with healthcare professionals is critical when concomitant medications are involved, particularly statins, anticoagulants, and antibiotics. Storage requirements for Ciprofibrate are straightforward — room temperature conditions away from light and moisture ensure stability. As a product from the storied catalogue of Refarmed Chemicals, now part of the DKSH Group, Ciprofibrate is accompanied by dependable documentation for Detailed and Master Files, affirming its reputable standard in pharmaceutical resources.

Products still subject to third-party patent protection might be available solely for R&D purposes.

Refarmed Chemicals presents Alacepril, a premium-grade antihypertensive medication catering to the pharmaceutical industry's mandate for efficacy and safety. This ACE (Angiotensin-converting enzyme) inhibitor is an integral pharmaceutical compound used in the treatment of hypertension and to mitigate the risk of myocardial infarction in patients with left ventricular dysfunction. By inhibiting ACE, Alacepril decreases the production of angiotensin II, resulting in vasodilation, reduced vascular resistance, and consequently, lower blood pressure. Constructed as a white crystalline powder, Alacepril is noted for its commendable solubility in methanol and ethanol (95%), with moderate solubility in water, facilitating its versatile use in different medicinal formulations. With quality as its cornerstone, Alacepril assures a high purity level, with an assay (by titration) confirming a 98.0% to 101.0% concentration for optimal therapeutic benefit. Each impurity is rigorously controlled to ≤ 0.2% and total impurities to ≤ 0.5%, ensuring compliance with robust pharmaceutical standards. Alacepril is packaged with comprehensive documentation, including DMF and JDMF certifications, and is produced under EU GMP guidelines, reflecting an unwavering commitment to regulatory conformance and product integrity. Precautionary measures are accounted for, with guidelines established for patients with hepatic or renal impairment, and contraindications identified for populations at risk, including during pregnancy and when potential for specific drug interactions exists. With a rapid absorption and an onset of action within 1-2 hours, Alacepril maintains its therapeutic efficacy for approximately 24 hours, making it a convenient once-daily treatment. Renal excretion serves as its primary elimination pathway, underscoring the need for tailored dose adjustments in patients with renal impairment. Trust Alacepril from Refarmed Chemicals for effective blood pressure management, anchored by our dedication to safety, efficacy, and quality control. Experience the synergy of cutting-edge pharmaceutical science and comprehensive patient care with Alacepril—a flagship example of our mission to support health and well-being.

Products still subject to third-party patent protection might be available solely for R&D purposes.